Derek Small

Derek A. Small is the founder of Luson Bioventures LLC, founded in 2007, serving as Managing Director.
Mr. Small was the founder of Assembly Biosciences, Inc., founded in 2014, serving as Director from 2019 to 2020.
Mr. Small was the founder of Assembly Pharmaceuticals, Inc., founded in 2012, serving as Executive Chairman & Chief Executive Officer.
Mr. Small was the founder of Gate Neurosciences, Inc., founded in 2018, serving as Executive Chairman.
Mr. Small is the founder of Monument Biosciences, Inc., founded in 2022, serving as Chief Executive Officer.
Mr. Small is also the founder of Syndeio Biosciences..
Mr. Small is currently a Director at Anagin, Inc. Mr. Small is currently a Board Member at BioCrossroads since 2017.
Former positions include Advisor & CEO at EndGenitor Technologies, Inc. from 2007 to 2009; President, Chief Executive Officer & Director at Naurex, Inc. from 2012 to 2014; President, Chief Executive Officer & Director at BlinkBio, Inc. from 2008 to 2011 and from 2009 to 2012; Director-Strategic Alliances at Simdesk Technologies, Inc.; Independent Director at Innoviva, Inc. from 2024 to 2026; Head-Business Development & Regulatory Affairs at Semafore Pharmaceuticals, Inc.; and Advisor at Kinagen, Inc. Education includes undergraduate studies at Franklin College of Indiana, Inc. and Harlaxton College.